Mende, N., Kuchen, E., Lesche, M., Grinenko, T., Kokkaliaris, K. D., Hanenberg, H., . . . Waskow, C. (2015). CCND1-CDK4-mediated cell cycle progression provides a competitive advantage for human hematopoietic stem cells in vivo. Journal of experimental medicine, 212(8), . https://doi.org/10.1084/jem.20150308
Chicago-Zitierstil (17. Ausg.)Mende, Nicole, et al. "CCND1-CDK4-mediated Cell Cycle Progression Provides a Competitive Advantage for Human Hematopoietic Stem Cells in Vivo." Journal of Experimental Medicine 212, no. 8 (2015). https://doi.org/10.1084/jem.20150308.
MLA-Zitierstil (9. Ausg.)Mende, Nicole, et al. "CCND1-CDK4-mediated Cell Cycle Progression Provides a Competitive Advantage for Human Hematopoietic Stem Cells in Vivo." Journal of Experimental Medicine, vol. 212, no. 8, 2015, https://doi.org/10.1084/jem.20150308.